Addressing the Clinical Feasibility of Adopting Circulating miRNA for Breast Cancer Detection, Monitoring and Management with Artificial Intelligence and Machine Learning Platforms

被引:8
作者
Ling, Lloyd [1 ]
Aldoghachi, Ahmed Faris [2 ]
Chong, Zhi Xiong [3 ]
Ho, Wan Yong [3 ]
Yeap, Swee Keong [4 ]
Chin, Ren Jie [1 ]
Soo, Eugene Zhen Xiang [1 ]
Khor, Jen Feng [1 ]
Yong, Yoke Leng [5 ]
Ling, Joan Lucille [6 ]
Yan, Naing Soe [2 ]
Ong, Alan Han Kiat [2 ]
机构
[1] Univ Tunku Abdul Rahman, Lee Kong Chian Fac Engn & Sci, Kajang 43000, Malaysia
[2] Univ Tunku Abdul Rahman, M Kandiah Fac Med & Hlth Sci, Kajang 43000, Malaysia
[3] Univ Nottingham Malaysia, Fac Sci & Engn, Sch Pharm, Div Biomed Sci, Semenyih 43500, Malaysia
[4] Xiamen Univ Malaysia, China ASEAN Coll Marine Sci, Sepang 43900, Malaysia
[5] Sunway Univ, Dept Comp & Informat Syst, Petaling Jaya 47500, Malaysia
[6] Arizona State Univ, Edson Coll Nursing & Hlth Innovat, Phoenix, AZ 85004 USA
关键词
liquid biopsy; circulating miRNA; breast cancer; AI; ML; BIOMARKERS; MICRORNAS; EXPRESSION; SURVIVAL; IDENTIFICATION; CHEMOTHERAPY; DIAGNOSIS;
D O I
10.3390/ijms232315382
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Detecting breast cancer (BC) at the initial stages of progression has always been regarded as a lifesaving intervention. With modern technology, extensive studies have unraveled the complexity of BC, but the current standard practice of early breast cancer screening and clinical management of cancer progression is still heavily dependent on tissue biopsies, which are invasive and limited in capturing definitive cancer signatures for more comprehensive applications to improve outcomes in BC care and treatments. In recent years, reviews and studies have shown that liquid biopsies in the form of blood, containing free circulating and exosomal microRNAs (miRNAs), have become increasingly evident as a potential minimally invasive alternative to tissue biopsy or as a complement to biomarkers in assessing and classifying BC. As such, in this review, the potential of miRNAs as the key BC signatures in liquid biopsy are addressed, including the role of artificial intelligence (AI) and machine learning platforms (ML), in capitalizing on the big data of miRNA for a more comprehensive assessment of the cancer, leading to practical clinical utility in BC management.
引用
收藏
页数:18
相关论文
共 101 条
  • [1] Ahmed Mohmmed Elham, 2021, Asian Pac J Cancer Prev, V22, P3513, DOI 10.31557/APJCP.2021.22.11.3513
  • [2] Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer
    Ahmed, Sarah Hamdy
    Espinoza-Sanchez, Nancy A.
    El-Damen, Ahmed
    Fahim, Sarah Atef
    Badawy, Mohamed A.
    Greve, Burkhard
    El-Shinawi, Mohamed
    Goette, Martin
    Ibrahim, Sherif Abdelaziz
    [J]. PLOS ONE, 2021, 16 (04):
  • [3] Impact of circulating miRNA-373 on breast cancer diagnosis through targeting VEGF and cyclin D1 genes
    Bakr, Noha M.
    Mahmoud, Magda Sayed
    Nabil, Reem
    Boushnak, Hussein
    Swellam, Menha
    [J]. JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2021, 19 (01)
  • [4] Model Comparison for Breast Cancer Prognosis Based on Clinical Data
    Boughorbel, Sabri
    Al-Ali, Rashid
    Elkum, Naser
    [J]. PLOS ONE, 2016, 11 (01):
  • [5] Identification of Circulating MicroRNA Signatures for Breast Cancer Detection
    Chan, Maurice
    Liaw, Chiew Suan
    Ji, Shen Mo
    Tan, Hwee Huang
    Wong, Chow Yin
    Thike, Aye Aye
    Tan, Puay Hoon
    Ho, Gay Hui
    Lee, Ann Siew-Gek
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (16) : 4477 - 4487
  • [6] RETRACTED: Effective Image Processing and Segmentation-Based Machine Learning Techniques for Diagnosis of Breast Cancer (Retracted Article)
    Chaudhury, Sushovan
    Krishna, Alla Naveen
    Gupta, Suneet
    Sankaran, K. Sakthidasan
    Khan, Samiullah
    Sau, Kartik
    Raghuvanshi, Abhishek
    Sammy, F.
    [J]. COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [7] Simple and fast isolation of circulating exosomes with a chitosan modified shuttle flow microchip for breast cancer diagnosis
    Chen, Wenwen
    Cao, Rongkai
    Su, Wentao
    Zhang, Xu
    Xu, Yuhai
    Wang, Peng
    Gan, Zhongqiao
    Xie, Yingying
    Li, Hongjing
    Qin, Jianhua
    [J]. LAB ON A CHIP, 2021, 21 (09) : 1759 - 1770
  • [8] Roles of circulating microRNA(s) in human breast cancer
    Chong, Zhi Xiong
    Yeap, Swee Keong
    Ho, Wan Yong
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2020, 695
  • [9] Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer
    Cuk, Katarina
    Zucknick, Manuela
    Madhavan, Dharanija
    Schott, Sarah
    Golatta, Michael
    Heil, Joerg
    Marme, Frederik
    Turchinovich, Andrey
    Sinn, Peter
    Sohn, Christof
    Junkermann, Hans
    Schneeweiss, Andreas
    Burwinkel, Barbara
    [J]. PLOS ONE, 2013, 8 (10):
  • [10] miR-21 Plays a Dual Role in Tumor Formation and Cytotoxic Response in Breast Tumors
    Dan, Tu
    Shastri, Anuradha A.
    Palagani, Ajay
    Buraschi, Simone
    Neill, Thomas
    Savage, Jason E.
    Kapoor, Aastha
    DeAngelis, Tiziana
    Addya, Sankar
    Camphausen, Kevin
    Iozzo, Renato, V
    Simone, Nicole L.
    [J]. CANCERS, 2021, 13 (04) : 1 - 16